Emerging Microbes & Infections · 2021 · 29 citations · 30 references
Life SciencesImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyImmune Response To VaccinationPrime-boost ImmunizationVaccinationVector-based VaccinesViral VaccinesViral Vector VaccinesAdenoviral Vaccine VectorsAdenoviral VectorsAdenovirus VaccinesAdenovirus VectorsPrime-boost Immunization RegimensPrime-boost Vaccination RegimensT Cell Response InductionViral Vector Immunogenicity
T cell (0.39%/0.55%) to S peptides were detected in vaccinated macaques. It was concluded that prime-boost immunization with Sad23L-nCoV-S and Ad49L-nCoV-S can safely elicit strong immunity in animals in preparation of clinical phase 1/2 trials.
30
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls, Young‐Jun Park, M. Alejandra Tortorici et al. · Cell · 2020 · 9.1K citations · Full text
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael et al. · New England Journal of Medicine · 2020 · 3.5K citations · Full text
Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin et al. · Nature · 2020 · 1.6K citations · Full text